峰瑞资本
@author-1781068851320
FreeS Report 20 | Learning from History: Why We're Bullish on Industrial Robots?
A Brief History of Industrial Robot Development in Germany, Japan, and the US, and China's Opportunity
FreeS Fund Wins Multiple Awards from 36Kr, Jiemian, Sansheng, and Lieyunwang | Frees Fund Vol.5
Do what is right, not what is easy.
Li Feng in Conversation with Academician Shao Feng: New Trends in Drug Discovery
How Can Basic Research Better Connect with Industry in Biomedicine, a Field Where "the Barrier to Entry Is Low, but the Courtyard Runs Deep"?
Wang Liming: Another Breakthrough in AI Protein Structure Prediction — What Does It Mean?
Brute force makes miracles?
Building a Brand Is Starting to Look Like Building an App — What Can Consumer Brands Learn From Super Apps About Growth? | FreeS Research
Five Brand Strategies for the New Media Era
Why Is AI Drug Discovery So Hot, and Why Now? | FreeS Fund Biomedical VC Summit Transcript
Why We're Bullish on AI Drug Discovery
The Secret Behind Instant Food's Explosive Popularity, Explained in 4 Minutes | FreeS Fund Daily Business Insights
Follow FreeS Fund's video channel for the latest observations from the world of venture capital.
How to Break Through Innovation with the Power of Interdisciplinary Collaboration? | FreeS Fund Biomedical and Pharmaceutical Investment Summit Transcript
What should you do if you discover a mismatch between technology and market?
Li Feng in Conversation with Academician Shao Feng: First In Class in China | Last 2 Days to Register
How can basic biomedical research better connect with industry?
Blue Ocean Strategy: How Early-Stage Biopharma Startups Can Break Through and Win with Big Pharma | FreeS Fund 2020 Biopharma Summit Session 3 — Registration Open
From "Me Worse" to "First in Class": How Can Biopharma Companies Compete Through Differentiation?
Why Is AI Drug Discovery So Hot? And How Long Will It Stay Hot? | FreeS Fund Events & Research Recs
Three Slightly Brain-Burning Little Gifts
FreeS Fund's Li Feng: Consumer Brands Go From 0 to 1 Easily, But 1 to 10 Is Hard | 10/31 Closed-Door Session Registration
When everyone's doing Douyin, Bilibili, livestreaming... what are the truly sustainable dividends?